Close

Form 8-K VERDE BIO HOLDINGS, INC. For: May 12

June 3, 2021 6:01 AM EDT

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934

Date of Report (Date of earliest event reported): May 12, 2021

 

VERDE BIO HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

Nevada

 

000-54524

 

30-0678378

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

5750 Genesis Court, Suite 220

Frisco, Texas 75034

(Address of Principal Executive Offices)

 

 

(972) 217-4080

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 1.01 Entry into Material Definitive Agreement

 

On April 22, 2021, Verde Bio Holdings, Inc. (the “Company”) announced that it had entered into an agreement for the settlement of various loans provided by GHS Investments, LLC pursuant to various convertible promissory notes (the “Loans”). The Company agreed to pay $715,000 to settle all matters related to the Loans (the “Settlement Amount”).

 

A form of the Settlement Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K.

 

On May 5, 2021, Verde Bio Holdings, Inc. (the “Company”) announced that it had entered into an agreement for marketing and sales consulting services (the “Services”) with Gilbert Steedley, Managing Member of INU, LLC (the “Consultant”) whereby the Consultant agreed to perform the Services in exchange for 3,000,000 shares of restricted common stock, a monthly per diem of 100,000 shares and $4,000, and a success fee of 7,000,000 shares of restricted common stock.

 

A form of the Consulting Agreement is filed as Exhibit 10.2 to this Current Report on Form 8-K.

 

Item 9.01

 

Financial Statements and Exhibits.

 

Exhibits. The following exhibits are being filed herewith:

 

 Exhibit Number

 

Description of Exhibits

10.1

 

Settlement Agreement

10.2

 

Consulting Agreement


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 2nd day of June, 2021.

 

 

VERDE BIO HOLDINGS, INC.

 

 

 

 

By:  

/s/ Scott A. Cox

 

 

 

Name: 

Scott A. Cox

 

 

 

Title:  

Chief Executive Officer

 

 

SETTLEMENT, RELEASE AND HOLD HARMLESS

THIS SETTLEMENT, RELEASE AND HOLD HARMLESS (“Agreement”) is made and entered into as of the 22nd day of April, 2021 by and between Verde Bio Holdings, Inc., a Nevada corporation (“Verde”) and GHS Investments, LLC, a Nevada limited liability company (“GHS”).

Background

A.Pursuant to various convertible promissory notes (collectively, the “Notes”), GHS has provided Verde with multiple loans (the “Loans”), including, but not limited to, the loans set forth on Appendix A.   

B.The parties desire to enter into this Agreement for the purpose of settling all matters related to the Loans and the Notes and release the parties from any and all claims relating thereto.  

Agreement

NOW, THEREFORE, in consideration of the mutual promises and covenants herein set forth and for other good and valuable consideration, the receipt, adequacy and legal sufficiency of which are hereby acknowledged, the parties mutually agree as follows:

1.Payment.  In satisfaction of Obligations (as defined below), Verde agrees to pay GHS the amount of seven hundred fifteen thousand and no/100 dollars ($715,000) (the “Settlement Amount”), payable as follows:  

(a)On or before April 23, 2021, Verde shall deliver to GHS, via wire transfer, the amount of $650,000.00, and  

(b)Verde shall issue to GHS 6,500,000 shares of its common stock being issued pursuant to the Reg A filing, qualified on January 19, 2021, to be issued within 4 business days of execution of this Agreement. 

2.Release of Obligations.  Upon receipt by GHS of the Settlement Amount, GHS agrees to release Verde from any and all debts, claims, obligations, loans, amounts owed and other obligations liabilities under the Loans the Notes (the “Obligations”).  Each Party acknowledges that (a) the consideration set forth in this Agreement, which includes, but is not limited to, the Settlement Amount, is in full settlement of the Obligations of whatsoever kind or character that they have, or may ever have had, against the other including, but not limited to any debts, claims, obligations or liabilities related to the Notes or the Loans. 

3.Release.  Each party does hereby release and forever discharge the other party and each of their respective officers, directors, shareholders, attorneys, predecessors, successors, representatives, insurers, assignees, agents, employees and all persons acting by, through, or in any way on behalf of the Party (“Released Parties”), of and from any and all claims, debts, defenses, liabilities, costs, attorneys’ fees, actions, suits at law or equity, demands, contracts, expenses, damages, whether general, specific, punitive, exemplary, contractual or extra-contractual, and causes of action of any kind or nature which the party may now have or claim to have against the other that are related directly or indirectly to the Obligations, Loans and the Notes,  


including without limitation all claims or causes of action which in any way, directly or indirectly, or in any other way arises from or are connected with or which could have been asserted in connection with the Loans or Notes, and any claim, cause of action, damages, promises or demands which could have been asserted in connection therewith; and the Released Parties further covenant and agree that this Agreement may be pleaded or asserted by or on behalf of the Released Parties as a defense and complete bar to any action or claim that may be brought against or involving Released Parties by anyone acting or purporting to act on behalf of  the Party with respect to any of the matters within the scope of this Agreement excepting only the obligations of the Released Parties under this Agreement. This full and final release shall cover and shall include and does cover and does include any and all known or future damages not now known to any of the parties hereto, but which may later develop or be discovered, including the effects and consequences thereof, and including all causes of action therefore which arise out of the same facts as were alleged or could have been alleged. 

4.Right of First Offer 

(a)Right of First Offer. Subject to the terms and conditions of this Section 4 and applicable securities laws, if the Company proposes to offer or sell any shares of its common stock pursuant to its current offering under Regulation A (“New Securities”), the Company shall first offer such New Securities to GHS.    

(b)The Company shall give notice (the “Offer Notice”) to GHS, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities. 

(c)By notification to the Company within three (3) trading days after the Offer Notice is given, GHS may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, such New Securities.  The Company shall use its reasonable best efforts to provide that closing of any sale pursuant to this Section 0 shall occur within the later of ten(10) trading days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Section 0. 

(d)If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Section 0, the Company may offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice.  

(a)The right of first offer set forth in this Section 4 shall terminate with respect to GHS, if GHS fails to purchase, in any transaction subject to this Section4, all of the New Securities offered GHS pursuant to this Section 4.  

5.Miscellaneous.   

(a)This Agreement constitutes the entire understanding between the parties hereto with respect to the subject matter hereof and supersedes all negotiations, representations, prior discussions and preliminary agreements between the parties hereto relating to the subject matter of this Agreement.   


2


(b)This Agreement shall be construed as though all parties had drafted it.   

(c)This Agreement shall inure to and bind the successors, assigns, heirs, devisees, executors, administrators, and personal representatives of the respective parties hereto.   

(d)Any waiver by any party hereto of any breach of any kind or character whatsoever by any other party, whether such waiver be direct or implied, shall not be construed as a continuing waiver of, or consent to, any subsequent breach of this Agreement on the part of the other party or parties.   

(e)No course of dealing or performance between the parties hereto, nor any delay in exercising any rights or remedies hereunder or otherwise, shall operate as a waiver of any of the rights or remedies of any party hereto.  

(f)The provisions of this Agreement are severable.  In addition, it is the intention and agreement of the parties that all of the terms and conditions hereof be enforced to the fullest extent permitted by law.   

(g)This Agreement may not be modified except by an instrument in writing and signed by all the parties hereto.  All warranties, representations, indemnities, covenants and other agreements of the parties set forth herein shall survive the execution, delivery and termination of this Agreement and shall, notwithstanding the execution, delivery and termination of this Agreement, continue in full force and effect.   

(h)If a legal action or other proceeding is brought because of an alleged dispute, breach, default or misrepresentation in connection with any provision of this Agreement, the party that prevails by enforcing this Agreement shall be entitled to recover reasonable attorney's fees, expenses and costs incurred, both before and after judgment, in addition to any other relief to which they may be entitled.   

(i)The law of the State of Nevada shall govern this Agreement for all purposes.   

(j)This Agreement may be executed in any number of counterparts and/or telecopied counterparts, each of which, when executed and delivered, will be deemed an original, but all of which will together constitute one and the same instrument. 

[Signature Page Follows]


3


 

IN WITNESS WHEREOF, the parties hereto have signed and executed this Agreement to be effective as of the date first above written.

VERDE BIO HOLDINGS, INC.:

By:   

Name:   

Its:   

GHS INVESTMENTS, LLC

By:   

Name:   

Its:   


4


APPENDIX A

Note Date

Amount of P&I

Principal

Interest

Premium

Rare

11/3/2020

$36,572.60 

$35,000.00 

$1,572.60 

$45,715.75 

25% 

9/10/2020

$37,090.41 

$35,000.00 

$2,090.41 

$48,217.53 

30% 

5/28/2020

$21,769.86 

$20,000.00 

$1,769.86 

$32,654.79 

50% 

3/25/2020

$14,378.36 

$13,000.00 

$1,378.36 

$21,567.53 

50% 

1/23/2020

$75,994.25 

$68,000.00 

$7,994.25 

$113,991.37 

50% 

1/14/2020

$39,391.78 

$35,000.00 

$4,391.78 

$59,087.67 

50% 

11/13/2019

$32,209.66 

$28,193.11 

$4,016.55 

$48,314.49 

50% 

9/12/2019

$38,261.92 

$33,000.00 

$5,261.92 

$57,392.88 

50% 

3/15/2019

$43,476.16 

$36,000.00 

$7,476.16 

$65,214.25 

50% 

10/4/2017

$11,744.83 

$11,690.38 

$54.45 

$17,617.25 

50% 

7/12/2017

$96,625.22 

$55,000.00 

$41,625.22 

$144,937.83 

50% 

3/15/2017

$26,797.73 

$15,000.00 

$11,797.73 

$40,196.59 

50% 

2/17/2017

$13,329.32 

$10,000.00 

$3,329.32 

$19,993.97 

50% 

 

 

 

 

 

 

Total

$487,642.10 

$394,883.49 

$92,758.61 

$714,901.92 

 


5

CONSULTING AGREEMENT

 

This CONSULTING AGREEMENT is made effective as of the date set forth below by and between Gilbert Steedley, Managing Member of INU, LLC (the “Consultant”) and Verde Bio Holdings, Inc., (VBHI or the “Company”).

Recitals

 

The Consultant has certain expertise related to the Company’s operations.

 

The Company desires to obtain the consulting services of the Consultant and the Consultant desires to provide such services in accordance with the terms hereof. Agreement NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth herein, the parties hereby agree as follows:

 

The Company hereby retains the Consultant to provide the Company with the consulting services set forth on Schedule A (the “Services”), and the Consultant hereby agrees to perform the Services, on the terms and conditions hereinafter set forth herein, including in Schedule A. The Consultant shall perform the Services in a timely and professional manner consistent with industry standards.

 

1.Fees and Expenses. 

 

(a)This Agreement shall be in effect until either party terminates this Agreement upon written notice (the “Term”); otherwise, for a minimum of twelve (12) months. 

 

(b)The sole compensation payable to the Consultant shall be 3,000,000 shares to begin ($.01 current value) of restricted common stock and a monthly per diem of 100,000 shares $4000 dollars as set forth. Payment is due by the 15th of each month. Payment is to be sent to using INU’s bank account as provided. 

 

(c)Success fee on any actual sale of VBHI resulting in a change of control. If VBHI shall be sold such that there is a legal “change of control” as that term is used in the capital market space, Consultant shall be entitled to issuance of 7,000,000 common restricted shares. These shares are speculative and shall not accrue unless VBHI executes definitive documents for said change of control. 

 

2.Ownership of Intellectual Property. 

 

a) The Consultant acknowledges that no license, right, or other indicia of ownership relating to any proprietary rights of the Company shall be granted or transferred by the Company to the Consultant by virtue of any provision of this Agreement or the performance of the Services as contemplated hereunder. The Consultant further acknowledges that all work performed by the Consultant under this Agreement are works produced for hire and constitute the sole and exclusive property of the Company.

 

3.Consulting Contract – to the Company all proprietary rights, including, without limitation, to all patents (and applications therefor), copyrights, trade secrets and trademarks the Consultant might otherwise have, by operation of law or otherwise, in all inventions, discoveries, creations, properties, works, ideas, information, laboratory notebooks, knowledge and data developed, reduced to practice or otherwise identified in connection with or related to the Consultant’s access to Confidential Information 


(as defined below) or performance of the Services as contemplated hereunder. The Consultant further agrees to execute and deliver any additional documents, instruments, applications, oaths or other writings necessary or desirable to further evidence the assignment described in this Section 3 (“Supporting Documents”). If the Consultant fails or refuses to execute or deliver any Supporting Documents, the Consultant hereby agrees, for itself and its employees, successors, assigns, donees, executors, administrators, transferees and personal representatives, to the fullest extent permitted by law, that the Chief Executive Officer of the Company shall be appointed, and the same is hereby irrevocably appointed, the Consultant’s attorney‐in‐fact with full authority to execute Supporting Documents and perform all other acts necessary to further evidence such assignment. The Consultant represents that he has the authority to assign the foregoing rights to the Company and that such an assignment does not violate any guidelines, policies, or other requirements imposed on the Consultant by his employer, if applicable. The Consultant shall not perform any Services during the time that the Consultant is required to devote to any third party. The Consultant shall not use the funding, resources or facilities of any third party to perform the Services and shall not perform any Services in any manner that would give any third‐party rights to the product of such work.

 

4.Confidential Information. 

 

(a)The Consultant shall not disclose to any third party or use for any purposes other than the performance of the Services any Confidential Information (as defined below), without Company’s prior written consent. The Consultant shall treat the Confidential Information as it would treat its own most proprietary and confidential information, but in no event shall it use less than a reasonable degree of care. Consultant shall be responsible for entering into similar confidentiality arrangements or agreements with its managers, officers, employees, agents and advisors (collectively, “Representatives”) who need to know such Confidential Information, and who agree to use such information solely) for the purpose of providing the Services. Consultant shall be responsible for any breach of this agreement by any of its Representatives. The obligation of non‐disclosure and non‐use shall not apply to the following: 

 

(i) information, which at the time of disclosure hereunder, is generally available to the public; (ii) information, which after disclosure hereunder, becomes generally available to the public, except through the Consultant’s breach of this Agreement; (iii) information that becomes available to the Consultant from a third party that is not legally prohibited from disclosing such information, provided such information was not acquired directly or indirectly from the Company; (iv) information, to the extent that it is required to be disclosed by lawful subpoena, court order or written demand of a federal or state governmental agency, of which the Consultant will immediately notify the Company giving Company an opportunity to object and/or seek confidential treatment.

 

(b)All Confidential Information; however, and wherever produced, including, without limitation, Confidential Information stored in computer databases or by other electronic means, shall be and remain the sole property of the Company. At any time upon the request of the Company, or without such request upon termination of the Consultant’s role as a consultant to the Company for whatever reason, the Consultant shall deliver to the Company (without retaining any electronic or physical copies, extracts, or other reproductions) or destroy immediately upon the Company’s request all documents and electronic storage devices that contain Confidential Information and that are in the Consultant’s possession or subject to its control, including, without limitation, any and all records, drawings, notebooks, memoranda, and computer diskettes. In addition, the Consultant shall return to the 


Company any equipment, tools, or other devices owned by the Company and in the Consultant’s possession.

 

(c)“Confidential Information” means any and all oral, written, tangible and/or intangible technical, scientific, financial, business and/or other information and/or Trade Secrets of the Company (including any information developed by the Consultant, which is the property of the Company under Section 3 in connection with this Agreement) that is confidential, proprietary and/or not generally available outside of the Company including, without limitation, (i) confidential and proprietary information supplied by the Company to the Consultant (whether or not marked “Confidential” or the equivalent thereof), (ii) the Company’s marketing and customer support strategies, financial information (including sales, costs, profits and pricing methods), internal organization, employee information and customer lists and other data and information relating to the business of the Company, (iii) the Company’s technology, including without limitation discoveries, inventions, research and development efforts, data, physical and chemical formulations, formulation techniques, compound characteristics, product specifications, manufacturing processes and operations, compositions, analytical methodology, safety and efficacy data, and testing data, patents, patent applications, trademarks, trade secrets, processes, programs, formulas, methods, products, know‐how and show‐how, (iv) all derivatives, improvements, additions, modifications and enhancements to any of the above, (v) information of third parties as to which the Company has an obligation of confidentiality or a duty to use such information only for certain limited purposes, and (vi) the terms of this Agreement. Trade Secret. It is also agreed by the Consultant that the Confidential Information as defined herein, are Trade Secrets of the Company under the Uniform Trade Secrets Act as adopted by the State of Texas under Texas Civil Practices & Remedies Code § 134A.002. This definition also includes, but is not limited to, investors, shareholders, vendors, contractors, purchasers, suppliers and their respective contact information such as phone numbers, email addresses, mailing addresses, etc... 

 

(d)During the term of this Agreement, the Consultant agrees to properly protect any proprietary information or trade secrets of the Consultant’s former or concurrent consultees, employers or companies (or those of its respective employees or principals), if any, and agrees not to bring onto the premises of the Company any unpublished documents or any property belonging to such persons or companies unless consented to in writing (which consent shall be provided to the Company in advance) by those persons or companies. The Consultant further recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and, in some cases, to use it only for certain limited purposes. The Consultant agrees, both during the term of the Consultant’s engagement and thereafter, to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation (except in a manner that is consistent with the Company’s agreement with the third party) or use it for the benefit of anyone other than the Company or such third party (consistent with the Company’s agreement with the third party). 

 

5.Company Policies. If, at any time, the Consultant is required to work at any of the Company’s premises or use any of its equipment, the Consultant will comply with all relevant health, safety and security regulations and related instructions issued by the Company. 

 

6.Term and Termination. (a) This Agreement shall be effective as of the date stated above and shall continue until the end of the Term. (b) Promptly after the termination or expiration of this Agreement, 


the Consultant shall return to the Company all whole and partial copies and derivatives of Confidential Information and other materials belonging to the Company that are in the Consultant’s possession or under the Consultant’s direct or indirect control. (c) The provisions of Sections 3, 4, and 6 shall survive the expiration or earlier termination of this Agreement.

 

7.Conflicts of Interest. The Consultant hereby represents and warrants that it, he or she is not a party to any existing agreement that will be breached by the Consultant’s performance of the Services or that conflict with the terms of this Agreement. During the Term, if the Consultant intends to enter into any activity, employment, or business arrangement that is in conflict with the Company’s interests or the Consultant’s obligations under this Agreement, then the Consultant agrees to notify the Company thereof prior to implementation and the Company shall have the right either (a) to approve the Consultant’s plans thereby waiving any conflict or (b) to terminate this Agreement immediately upon written notice to the Consultant. 

 

8.Waiver. A party’s failure to enforce, at any time or for any period of time, any provision of this Agreement, or to exercise any right or remedy, does not constitute a waiver of such provision, right or remedy, or prevent such party thereafter from enforcing any or all provisions and exercising any or all other rights and remedies. The exercise of any right or remedy does not constitute an election or prevent the exercise of any or all rights or remedies, all rights and remedies being cumulative. 

 

9.Notice. Any and all notices referred to herein shall be sufficient if furnished in writing and delivered by hand, by overnight delivery service maintaining records of receipt, to the respective parties at the following addresses: If to the Company: If to the Consultant: To the address set forth on the signature page. or to such other address or addresses as either party may from time to time designate by notice given as aforesaid. Notices shall be effective when delivered. 

 

10.Assignment. The Consultant shall not assign or transfer its, his or her interest or obligations under this Agreement, in whole or in part, without the prior written consent of the Company and any such assignment contrary to the terms hereof shall be null and void and of no effect. The Company may assign all its rights and liabilities under this Agreement to any of its affiliates or to a successor to all or a substantial part of its business or assets without the consent of the Consultant. The Consultant shall not subcontract any portion of the Services without the Company’s prior written consent. 

 

11.Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Texas, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in Dallas, Texas. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Texas for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence 


of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

12.Entire Agreement. This Agreement constitutes, on and as of the date hereof, the entire agreement of the parties with respect to the subject matter hereof, and all prior or contemporaneous understandings or agreements, whether written or oral, between the parties with respect to such subject matter are hereby superseded in their entireties. This Agreement shall not be amended in any respect whatsoever except by a further agreement, in writing, fully executed by each of the parties. 

 

13.Independent Contractors. The Consultant is hereby engaged as an independent contractor and not as an employee of the Company. The Consultant is providing the Services solely at its own direction and under its own supervision. Nothing herein shall be construed as creating an employer/employee relationship between Company and the Consultant or placing the parties in a partnership or joint venture relationship. The Consultant shall have absolutely no authority to bind, commit or otherwise obligate the Company in any way whatsoever nor shall it represent to any person that it has any such right or authority. Nothing in this Agreement shall be construed as establishing an agency, partnership, employer/employee or joint venture relationship between the parties hereto. 

 

14.Taxes. The Consultant shall pay and report all applicable local, state and federal taxes and insurance in connection with the Consultant’s receipt of payments under this Agreement. The Consultant further agrees to maintain workers’ compensation insurance in the amount required by the laws of the state in which the Consultant’s employees performing the Services are located. The Consultant shall provide the Company with a completed IRS Form W‐9, including his United States Tax Identification Number (TIN) upon execution of this Agreement. The Company shall provide the Consultant with an Internal Revenue Service (IRS) Form 1099 in connection with the performance of the Services. 

 

15.No Violation. The Consultant shall perform the Services in compliance with applicable federal, state, and local laws and regulations. The Consultant represents to the Company that its/his/her execution and performance of this Agreement does not violate any agreement, or other ethical policies, rules, or regulations to which the Consultant is subject or represent a conflict of interest. 

 

16.Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed to be an original, and all of which together shall constitute one agreement binding on the parties hereto. 

 

 

 

 

 

 

 

Signature Page Follows


IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date set forth below.

 

 

INU, LLC

 

 

By: Gilbert Steedley, Managing Member

Date: April 20, 2021

Address: 776 Bronx River Rd, Apt. B53.

Bronxville, NY 10708

 

Verde Bio Holdings, Inc.

 

 

By: Scott A. Cox, CEO

Date: April 28, 2021

5750 Genesis Court, Suite 220B

Frisco, Texas 75034


 

 

 

 

 

 

Schedule A

 

Consultant shall provide Services marketing and sales consulting for the capital markets.

 

 

 

 

 

 

*This list is not considered exhaustive and may be added to from time to time as agreed upon by both parties. 



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings